Peters F P, Brakenhoff K P M, Curvers W L, Rosmolen W D, ten Kate F J W, Krishnadath K K, Fockens P, Bergman J J G H M
Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands.
Dis Esophagus. 2007;20(6):510-5. doi: 10.1111/j.1442-2050.2007.00727.x.
This study aimed to prospectively evaluate the safety of endoscopic resection for early neoplasia in Barrett's esophagus (BE) using the endoscopic cap resection (ER cap) technique. All resections performed between September 2000 and March 2006 with the ER-cap technique in patients with BE were included. Complications were classified 'acute' (during the procedure) or 'early' (< 48 h after the procedure). A total of 216 ER-cap procedures were performed in 121 patients, of which 145 were performed with a standard hard cap and 71 with a large flexible cap. Specimens removed with the standard cap had a mean diameter of 20 mm (SD 5.0) versus 23 mm (SD 5.8) for the large cap (P < 0.001). Acute complications occurred in 51 procedures (24%), 49 bleedings and two perforations. All bleedings were effectively treated with hemostatic techniques and classified as mild complications. No patient experienced a drop in hemoglobin levels or required blood transfusions or repeat interventions. The two perforations were classified as severe complications and treated conservatively. Three (1%) early complications, all bleedings, occurred and were effectively treated with endoscopic hemostatic techniques and classified as moderately severe complications. In manova the indication for the resection (high-grade intraepithelial neoplasia or early cancer versus low-grade intraepithelial neoplasia or no dysplasia) was found to be significantly associated with an increased risk of acute bleeding. Endoscopic cap resection in BE is safe. Most complications become apparent immediately during the procedure and can be managed endoscopically. Bleeding after the endoscopic resection procedure and severe acute complications (i.e., perforations) are rare (2%).
本研究旨在前瞻性评估采用内镜帽切除术(ER帽)技术对巴雷特食管(BE)早期瘤变进行内镜切除的安全性。纳入了2000年9月至2006年3月期间采用ER帽技术对BE患者进行的所有切除术。并发症分为“急性”(手术过程中)或“早期”(手术后<48小时)。121例患者共进行了216次ER帽手术,其中145次使用标准硬帽,71次使用大型柔性帽。标准帽切除的标本平均直径为20mm(标准差5.0),而大型帽为23mm(标准差5.8)(P<0.001)。51例手术(24%)发生急性并发症,49例出血和2例穿孔。所有出血均采用止血技术有效治疗,分类为轻度并发症。没有患者血红蛋白水平下降,也无需输血或重复干预。2例穿孔分类为严重并发症,采用保守治疗。发生3例(1%)早期并发症,均为出血,采用内镜止血技术有效治疗,分类为中度严重并发症。在多变量分析中,发现切除指征(高级别上皮内瘤变或早期癌与低级别上皮内瘤变或无发育异常)与急性出血风险增加显著相关。BE的内镜帽切除术是安全的。大多数并发症在手术过程中立即显现,可通过内镜处理。内镜切除术后出血和严重急性并发症(即穿孔)很少见(2%)。